Pages that link to "Q44013878"
Jump to navigation
Jump to search
The following pages link to 6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: implications for the pathogenesis of Parkinson's disease (Q44013878):
Displaying 26 items.
- Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity (Q25256506) (← links)
- Development of an ischemic tolerance model in a PC12 cell line (Q33210797) (← links)
- Adaptation to chronic MG132 reduces oxidative toxicity by a CuZnSOD-dependent mechanism (Q33984045) (← links)
- Lack of neuroprotective effect of celastrol under conditions of proteasome inhibition by lactacystin in in vitro and in vivo studies: implications for Parkinson's disease (Q34085167) (← links)
- Beta-synuclein regulates Akt activity in neuronal cells. A possible mechanism for neuroprotection in Parkinson's disease (Q34306521) (← links)
- Mitochondrial function in human neuroblastoma cells is up-regulated and protected by NQO1, a plasma membrane redox enzyme (Q34852496) (← links)
- Protein kinase D1 (PKD1) phosphorylation promotes dopaminergic neuronal survival during 6-OHDA-induced oxidative stress. (Q35164624) (← links)
- Proteomic approach to studying Parkinson's disease (Q35794541) (← links)
- The plasma membrane redox enzyme NQO1 sustains cellular energetics and protects human neuroblastoma cells against metabolic and proteotoxic stress (Q35853701) (← links)
- Viral vector mediated overexpression of human alpha-synuclein in the nigrostriatal dopaminergic neurons: a new model for Parkinson's disease. (Q36060421) (← links)
- 6-Hydroxydopamine induces mitochondrial ERK activation. (Q36065903) (← links)
- L-DOPA treatment from the viewpoint of neuroprotection. Possible mechanism of specific and progressive dopaminergic neuronal death in Parkinson's disease (Q36285084) (← links)
- Proteomics in Parkinson's disease: current trends, translational snags and future possibilities (Q37685124) (← links)
- Can parkin be a target for future treatment of Parkinson's disease? (Q38127703) (← links)
- Cellular uptake of Nigella sativa oil-PLGA microparticle by PC-12 cell line. (Q39008600) (← links)
- Baicalein prevents 6-hydroxydopamine-induced mitochondrial dysfunction in SH-SY5Y cells via inhibition of mitochondrial oxidation and up-regulation of DJ-1 protein expression. (Q39052298) (← links)
- The extent of neurodegeneration and neuroprotection in two chemical in vitro models related to Parkinson's disease is critically dependent on cell culture conditions (Q39212503) (← links)
- Functional GPR37 trafficking protects against toxicity induced by 6-OHDA, MPP+ or rotenone in a catecholaminergic cell line (Q39250474) (← links)
- Rottlerin protected dopaminergic cell line from cytotoxicity of 6-hydroxydopamine by inhibiting PKCdelta phosphorylation (Q39820474) (← links)
- Parkin protects against neurotoxicity in the 6-hydroxydopamine rat model for Parkinson's disease (Q40242764) (← links)
- 6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta (Q40339108) (← links)
- Wnt3a protects SH-SY5Y cells against 6-hydroxydopamine toxicity by restoration of mitochondria function (Q42428091) (← links)
- Oxidative stress, induced by 6-hydroxydopamine, reduces proteasome activities in PC12 cells: implications for the pathogenesis of Parkinson's disease (Q45227787) (← links)
- The bipyridyl herbicide paraquat induces proteasome dysfunction in human neuroblastoma SH-SY5Y cells (Q46952368) (← links)
- Computer-Aided Design and Synthesis of 1-{4-[(3,4-Dihydroxybenzylidene)amino]phenyl}-5-oxopyrrolidine-3-carboxylic Acid as an Nrf2 Enhancer (Q59620601) (← links)
- Astrocyte-derived metallothionein protects dopaminergic neurons from dopamine quinone toxicity (Q83292616) (← links)